A pooled analysis of the prognostic value of PD-L1 in melanoma: evidence from 1062 patients

A pooled analysis of the prognostic value of PD-L1 in melanoma: evidence from 1062 patients

Abstract Background Programmed death-ligand 1 (PD-L1) was the first identified ligand of programmed death-1 (PD-1). PD-1/PD-L1 interactions inhibit T cell-mediated immune responses, limit cytokine production, and promote tumor immune escape. Recently, many studies have investigated the prognostic va...

Full description

Bibliographic Details
Main Authors: Jing Yang, Meilian Dong, Yifang Shui, Yue Zhang, Zhigang Zhang, Yin Mi, Xiaoxiao Zuo, Li Jiang, Ke Liu, Zheyan Liu, Xiaobin Gu, Yonggang Shi
Format: Article
Language:English
Published: BMC 2020-03-01
Series:Cancer Cell International
Subjects:
PD-L1
Meta-analysis
Prognosis
Melanoma
Risk factor
Online Access:http://link.springer.com/article/10.1186/s12935-020-01187-x

Internet

http://link.springer.com/article/10.1186/s12935-020-01187-x

Similar Items